Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Elena Santagostino & Maria Elisa Mancuso. (2018) GlycoPEGylated recombinant factor IX for hemophilia B in context. Drug Design, Development and Therapy 12, pages 2933-2943.
Read now
Read now
Claudia Djambas Khayat. (2016) Once-weekly prophylactic dosing of recombinant factor IX improves adherence in hemophilia B. Journal of Blood Medicine 7, pages 275-282.
Read now
Read now
Massimo Franchini. (2014) Current management of hemophilia B: recommendations, complications and emerging issues. Expert Review of Hematology 7:5, pages 573-581.
Read now
Read now
Pier Mannuccio Mannucci & Massimo Franchini. (2014) Emerging drugs for hemophilia B. Expert Opinion on Emerging Drugs 19:3, pages 407-414.
Read now
Read now
Jerzy Windyga, Brigitt E Abbuehl & Andrea E Hafeman. (2014) BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B. Expert Review of Hematology 7:3, pages 333-342.
Read now
Read now
Articles from other publishers (7)
Tiago J. S. Lopes, Tatiane Nogueira & Ricardo Rios. (2022) A Machine Learning Framework Predicts the Clinical Severity of Hemophilia B Caused by Point-Mutations. Frontiers in Bioinformatics 2.
Crossref
Crossref
Javad Parnian, Maryam Hoseindokht, Zahra Khademi, Maedeh Moosavi, Zahra Soheila Soheili, Shahram Samie & Alireza Zomorodipour. (2022) Calumenin knockdown, by intronic artificial microRNA, to improve expression efficiency of the recombinant human coagulation factor IX. Biotechnology Letters 44:5-6, pages 713-728.
Crossref
Crossref
Tim Preijers, Lisette M. Schütte, Marieke J. H. A. Kruip, Marjon H. Cnossen, Frank W. G. Leebeek, Reinier M. van Hest & Ron A. A. Mathôt. (2020) Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia. Clinical Pharmacokinetics 60:1, pages 1-16.
Crossref
Crossref
Solmaz Moniri Javadhesari & Alireza Zomorodipour. (2020) Improvement of the recombinant human coagulation factor IX expression by co-expression of a novel transcript of Drosophila γ carboxylase in a human cell line. Biotechnology Letters 42:11, pages 2147-2156.
Crossref
Crossref
Dorina Cultrera, Raimondo De Cristofaro, Paola Giordano, Silvia Linari, Silvia Macchi, Renato Marino, Angelo Claudio Molinari, Angiola Rocino, Cristina Santoro, Piercarla Schinco, Sergio Siragusa, Giuseppe Tagariello, Annarita Tagliaferri, Ezio Zanon & Massimo Morfini. (2020) Identification of the Profile of the Patients with Hemophilia B Eligible for Treatment with Nonacog Alfa Once-Weekly. Reports — Medical Cases, Images, and Videos 3:1, pages 3.
Crossref
Crossref
Hoda Motlagh, Behnaz Pezeshkpoor & Akbar Dorgalaleh. 2018. Congenital Bleeding Disorders. Congenital Bleeding Disorders
139
160
.
Jerzy Windyga, Maria Helena Solano Trujillo & Andrea E. Hafeman. (2014) BAX326 (RIXUBIS): a novel recombinant factor IX for the control and prevention of bleeding episodes in adults and children with hemophilia B. Therapeutic Advances in Hematology 5:5, pages 168-180.
Crossref
Crossref